Autologous Cell Therapy Market Size to Grow by USD 4.11 billion, Bayer AG and Brainstorm Cell Therapeutics Inc. Among Key Vendors – Technavio – QNT Press Release


NEW YORK, Aug. 1, 2022 /PRNewswire/ — The autologous cell therapy market is driven by factors such as the increasing demand for effective drugs for cardiac and degenerative disorders. However, factors such as critical ethical challenges with respect to stem cell research will challenge the growth of the market.

The autologous cell therapy market size is expected to grow by USD 4.11bn from 2020 to 2025. In addition, the growth momentum of the market will accelerate at a CAGR of 14.16% during the forecast period, according to Technavio.

Get a comprehensive report summary describing the market size and forecast along with research methodology. View our Sample Report

Autologous Cell Therapy Market 2021-2025: Scope

The autologous cell therapy market report covers the following areas:

Autologous Cell Therapy Market 2021-2025: Segmentation
  • Product
    • Autologous Stem Cell Therapy: The autologous stem cell therapy segment will contribute the highest market share. This segment is growing at a medium pace due to its manufacturing complexities. Vendors are conducting extensive clinical trials due to fewer complications associated with the use of autologous stem cell therapy.
    • Autologous Cellular Immunotherapies
  • Geography
    • North America: North America will account for 43% of the market’s growth during the forecast period. This growth is attributed to limitations in traditional organ transplantations, which is fueling the demand for stem cell therapies. Moreover, market growth in this region will be slower than the growth of the market in other regions. The US and Canada are the key countries for the autologous cell therapy market in North America.
    • Europe
    • APAC
    • South America
    • MEA

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

Autologous Cell Therapy Market 2021-2025: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the autologous cell therapy market, including Bayer…

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center